Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

Pittenger, Christopher, Bloch, Michael H., Williams, Kyle·2011·Pharmacology & Therapeutics
DOI 10.1016/j.pharmthera.2011.09.006

Cites (229)

Items 201–227 of 227

  1. Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder
    Christopher Pittenger, John Harrison Krystal, Vladimir Coric · 2005 · The Journal of Clinical Psychiatry
  2. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive‐compulsive disorder with compulsive hoarding
    Liang, Kung‐Yee, Wang, Ying, Shugart, Yin Yao, Grados, Marco, Fyer, Abby J., Rauch, Scott, Murphy, Dennis, McCracken, James, Rasmussen, Steven, Cullen, Bernadette et al. · 2008 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  3. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive–compulsive disorder patients
    Satsuki Sumitani, Masafumi Harada, Hitoshi Kubo, Tetsuro Ohmori · 2006 · Psychiatry Research Neuroimaging
  4. Sarcosine Therapy for Obsessive Compulsive Disorder
    Po-Lun Wu, Hwa‐Sheng Tang, Hsien‐Yuan Lane, Chen‐An Tsai, Guochuan Emil Tsai · 2011 · Journal of Clinical Psychopharmacology
  5. Genetic and imaging strategies in obsessive–compulsive disorder: potential implications for treatment development
    D.R. Rosenberg, Gregory L. Hanna · 2000 · Biological Psychiatry
  6. Platelet Serotonergic Markers as Endophenotypes for Obsessive-Compulsive Disorder
    Richard Delorme, Catalina Betancur, Jacques Callebert, Nadia Chabane, Jean Laplanche, Marie–Christine Mouren, Jean‐Marie Launay, Marion Leboyer · 2005 · Neuropsychopharmacology
  7. The role of the COMT Val158Met polymorphism in the phenotypic expression of obsessive‐compulsive disorder
    Hilga Katerberg, Daniëlle C. Cath, Damiaan A J P Denys, Peter Heutink, Annemiek Polman, Filip Van Nieuwerburgh, Dieter L. D. Deforce, Zoltán Bochdanovits, Anton J.L.M. van Balkom, Johan A. den Boer · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  8. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction
    Keith M. Campbell, Matthew B. Veldman, Michael J. McGrath, Frank H. Burton · 2000 · Neuroreport
  9. 1H-Spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the striatum
    Fritz Hohagen, D. Ebert, Oliver Speck, Armin König, M. Berger, Jürgen Hennig · 1997 · Biological Psychiatry
  10. Topiramate related obsessive–compulsive disorder
    Çiğdem Özkara, Mine Özmen, Ayten Erdoğan, İrem Yaluğ · 2004 · European Psychiatry
  11. Familiality of Obsessive-Compulsive Disorder in Nonclinical and Clinical Subjects
    Hans Jörgen Grabe · 2006 · American Journal of Psychiatry
  12. Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive–compulsive disorder
    Detlef E. Dietrich, Y Zhang, Liv Bode, TF Münte, Ute Hauser, P Schmorl, C Richter-Witte, T. Gödecke‐Koch, S Feutl, J Schramm et al. · 2005 · Molecular Psychiatry
  13. Neurochemistry of the hippocampus in patients with obsessive–compulsive disorder
    M. Atmaca, H. Yildirim, H. Ozdemir, M. Koç, Sinan Ozler, E. Tezcan · 2009 · Psychiatry and Clinical Neurosciences
  14. Obsessive-Compulsive Disorders: A Serotonergic Hypothesis
    J.A. YARYURA TOBIAS, Fugen A. Neziroglu, HEMMIGE N. BHAGAVAN · 1979 · Elsevier eBooks
  15. Effects of panic disorder treatments on personality disorder characteristics
    Stefan G. Hofmann, M. Katherine Shear, David Harrison Barlow, Jack M. Gorman, David Hershberger, Marcus D. Patterson, Scott W. Woods · 1998 · Depression and Anxiety
  16. Beneficial Effects of the Antiglutamatergic Agent Riluzole in a Patient Diagnosed With Trichotillomania
    Vladimir Coric, Ben Kelmendi, Christopher Pittenger, Susanne Wasylink, Michael H. Bloch, Jeff Green · 2007 · The Journal of Clinical Psychiatry
  17. The Genetics of Obsessive-Compulsive Disorder
    Michael H. Bloch, Christopher Pittenger · 2010 · Current Psychiatry Reviews
  18. High-Dose Glycine Treatment of Refractory Obsessive-Compulsive Disorder and Body Dysmorphic Disorder in a 5-Year Period
    W. Louis Cleveland, Robert L. DeLaPaz, Rashid A. Fawwaz, Roger S. Challop · 2009 · Neural Plasticity
  19. STREPTOCOCCAL INFECTION, TOURETTE SYNDROME, AND OCD: IS THERE A CONNECTION? PANDAS: HORSE OR ZEBRA?
    Susan E. Swedo · 2010 · Neurology
  20. Topiramate may induce obsessive‐compulsive disorder
    JACQUES THUILE, CHRISTIAN EVEN, Julien‐Daniel Guelfi · 2006 · Psychiatry and Clinical Neurosciences
  21. An Association of Intrusive, Repetitive Phrases with Lamotrigine Treatment in Bipolar II Disorder
    David E. Kemp, William S. Gilmer, Jenelle Fleck, Pedro Luis Dago · 2007 · CNS Spectrums
  22. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report
    Muhammet Mustafa Kuloğlu, A. Caykoylu, Okan Ekinci, E. Yilmaz · 2008 · Journal of Psychopharmacology
  23. The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.
    Raphael Wald, Nicholas H. Dodman, Louis Shuster · 2009 · Experimental and Clinical Psychopharmacology
  24. Using Individual Items to Clarify OCD Symptom Structure: The Case for Five Factors
    Anthony Pinto, Benjamin David Greenberg, Dennis L. Murphy, Gerald Nestadt, Steven A. Rasmussen · 2009 · American Journal of Psychiatry
  25. Can Dogs Behaving Badly Suggest a New Way to Treat OCD?
    Constance Holden, John Paul Travis · 2010 · Science
  26. Pour les tics et tocs, serait-ceSLITRK1?
    Jacques Epelbaum · 2005 · médecine/sciences
  27. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
    David J. Vinkers, N J A van der Wee · 2008 · PubMed